Tellus Therapeutics
Khadar received his Ph.D. from the Department of Cell Biology at Duke University. He conducted his postdoctoral work at Duke University on postnatal neurogenesis, adult hippocampal neurogenesis, ependymal development, and hydrocephalus. Khadar brings over 12 years of experience researching neural stem cells and related progenitor cells at both the subventricular zone and dentate gyrus. He is passionate about converting basic science knowledge into translatable therapies and will be leading the pipeline development program at Tellus Therapeutics as a senior scientist.
This person is not in any offices
Tellus Therapeutics
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury.